SC
Shilpa Chaitanya Reddy Kudumula
About Shilpa Chaitanya Reddy Kudumula
Data last updated:
Shilpa Chaitanya Reddy Kudumula is a Director at Deleton Lifesciences Private Limited (since 2021) and Designated Partner at Aaryapatha Pharma Llp (since 2020). The companies operate in Food And Beverages and Home Appliances. The largest current company by reported revenue is Deleton Lifesciences Private Limited at ₹39 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Deleton Lifesciences Private Limited U24304KA2017PTC108193 | Director | 06 Apr 2021 | 2017 | ₹39 Lakh (FY 2021) | Active |
| Aaryapatha Pharma Llp AAU-7960 | Designated Partner | 24 Nov 2020 | 2020 | Active |
Board colleagues of Shilpa Chaitanya Reddy Kudumula
| Name | DIN | Company | Designation |
|---|---|---|---|
| Indira Kattabelthur Sulse | 08970327 | Deleton Lifesciences Private Limited | Director |
| Manyam Venkatesh | 07976051 | Deleton Lifesciences Private Limited | Director |
| Keathineni Dinesh | 07976041 | Aaryapatha Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shilpa Chaitanya Reddy Kudumula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shilpa Chaitanya Reddy Kudumula
Shilpa Chaitanya Reddy Kudumula currently holds 2 directorships: Deleton Lifesciences Private Limited (Director, since 06 Apr 2021, revenue ₹39 Lakh (FY 2021)); Aaryapatha Pharma Llp (Designated Partner, since 24 Nov 2020).
Shilpa Chaitanya Reddy Kudumula was first appointed on 24 Nov 2020 as Designated Partner at Aaryapatha Pharma Llp. The most recent appointment on record is 06 Apr 2021 at Deleton Lifesciences Private Limited.
The current boards of Shilpa Chaitanya Reddy Kudumula's companies include Indira Kattabelthur Sulse (Deleton Lifesciences Private Limited), Manyam Venkatesh (Deleton Lifesciences Private Limited), Keathineni Dinesh (Aaryapatha Pharma Llp).